Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) FCF Margin (2017 - 2025)

Assembly Biosciences has reported FCF Margin over the past 8 years, most recently at 33.47% for Q4 2025.

  • Quarterly results put FCF Margin at 33.47% for Q4 2025, up 3900.0% from a year ago — trailing twelve months through Dec 2025 was 56.93% (up 12240.0% YoY), and the annual figure for FY2025 was 56.93%, up 12240.0%.
  • FCF Margin for Q4 2025 was 33.47% at Assembly Biosciences, up from 140.65% in the prior quarter.
  • Over the last five years, FCF Margin for ASMB hit a ceiling of 1027.17% in Q4 2023 and a floor of 317.68% in Q1 2024.
  • Median FCF Margin over the past 4 years was 187.34% (2024), compared with a mean of 55.14%.
  • Biggest five-year swings in FCF Margin: crashed -103270bps in 2024 and later skyrocketed 8205bps in 2025.
  • Assembly Biosciences' FCF Margin stood at 301.92% in 2021, then soared by 440bps to 1027.17% in 2023, then crashed by -101bps to 5.53% in 2024, then surged by 705bps to 33.47% in 2025.
  • The last three reported values for FCF Margin were 33.47% (Q4 2025), 140.65% (Q3 2025), and 174.09% (Q2 2025) per Business Quant data.